Back to Journals » Drug Design, Development and Therapy » Volume 14 » The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
Please verify you are not a robot.
Back to Journals » Drug Design, Development and Therapy » Volume 14 » The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
Please verify you are not a robot.